Astrosalva Therapeutics Adds Alexander Disease Scientist Natasha Snider, PhD, to Scientific Advisory Board
<p>UNC-Chapel Hill researcher studies GFAP, the protein whose mutations cause Alexander disease SAN MATEO, Calif., Nov. 19, 2026 /PRNewswire/ -- Astrosalva Therapeutics, Inc. ("Astrosalva"), a privately held, preclinical biotechnology company developing treatments for Alexander disease (AxD)...</p>
Read original article ↗
Related Articles
Built by former AWS metering leaders and already embedded in the Limina platform, Amberflo's technology takes Limina bey
BMO Uses IBM Quantum Computers to Identify Which Inputs Matter Most to AI Models
TORONTO, CHICAGO and SAN FRANCISCO, Nov. 19, 2026 — BMO today announced it has demonstrated quantum utility in a machine
HAMILTON, Ontario, et GARCHING, Allemagne, 19 novembre 2026 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), une or
AtomVie Global Radiopharma e ITM suscriben un acuerdo de suministro para lutecio-177 n.c.a.
HAMILTON, ON y GARCHING, Alemania, 19 de noviembre de 2026 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), una org